Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Lynparza regulatory submission granted Priority Review in the US for HRR-mutated metastatic castration-resistant prostate cancer
-
Lynparza regulatory submission granted Priority Review in the US for 1st-line maintenance treatment with bevacizumab in advanced ovarian cancer
-
Update on Phase III STRENGTH trial for Epanova in mixed dyslipidaemia
-
Farxiga granted FDA Priority Review for patients with heart failure with reduced ejection fraction
-
Lokelma approved in China for the treatment of adult patients with hyperkalaemia
-
Lynparza approved in the US as a 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer
-
AstraZeneca’s Mene Pangalos awarded knighthood in the New Year 2020 Honours List
-
AstraZeneca’s triple-combination therapy approved in China for patients with COPD
-
Enhertu (trastuzumab deruxtecan) approved in the US for HER2-positive unresectable or metastatic breast cancer following two or more prior anti-HER2 based regimens
-
AstraZeneca divests rights to Arimidex and Casodex in Europe and certain additional countries
Latest articles and press releases
All of our latest press releases and articles are available to explore
